Does ephedrine promote weight loss in low-energy-adapted obese women? 1987

R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo

A double-blind cross-over randomized study was performed in 10 selected adult overweight and obese (body mass index greater than 27) women who had been adapted to low-energy intake for a long period of time and who had shown difficulty in losing weight with conventional hypocaloric treatment. Combined with diet therapy (1000-1400 kcal/day), l(-)ephedrine hydrochloride (50 mg three times a day per os) or placebo were administered daily before each meal, after a period of stabilization with diet only for 1 month. Each pharmacological treatment lasted for 2 months. Weight loss was significantly (P less than 0.05) greater during the ephedrine period (2.41 +/- 0.61 kg) than during the placebo period (0.64 +/- 0.50 kg). None of the patients presented clinically important side-effects. These preliminary results seem to suggest a possible role for a thermogenic compound such as ephedrine in promoting weight loss in low-energy-adapted obese women.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004038 Diet, Reducing A diet designed to cause an individual to lose weight. Weight Loss Diet,Weight Reduction Diet,Diet, Weight Loss,Diet, Weight Reduction,Diets, Reducing,Diets, Weight Loss,Diets, Weight Reduction,Reducing Diet,Reducing Diets,Weight Loss Diets,Weight Reduction Diets
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D004809 Ephedrine A phenethylamine found in EPHEDRA SINICA. PSEUDOEPHEDRINE is an isomer. It is an alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used for asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists. Ephedrine Hydrochloride,Ephedrine Renaudin,Ephedrine Sulfate,Erythro Isomer of Ephedrine,Sal-Phedrine,Ephedrine Erythro Isomer,Hydrochloride, Ephedrine,Renaudin, Ephedrine,Sal Phedrine,SalPhedrine,Sulfate, Ephedrine
D005260 Female Females

Related Publications

R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo
January 1990, Transactions of the Association of American Physicians,
R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo
February 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo
October 1972, The American journal of clinical nutrition,
R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo
January 1995, La Tunisie medicale,
R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo
January 2002, International urogynecology journal and pelvic floor dysfunction,
R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo
June 2000, International journal of sport nutrition and exercise metabolism,
R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo
October 2011, The British journal of nutrition,
R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo
June 2002, The Journal of nutrition,
R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo
March 2005, The Journal of clinical endocrinology and metabolism,
R Pasquali, and M P Cesari, and N Melchionda, and C Stefanini, and A Raitano, and G Labo
September 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
Copied contents to your clipboard!